Authors: HEINEMANN V BOSSE D JEHN U KAHNY B WACHHOLZ K DEBUS A SCHOLZ P KOLB HJ WILMANNS W

Citation: V. Heinemann et al., PHARMACOKINETICS OF LIPOSOMAL AMPHOTERICIN-B (AMBISOME) IN CRITICALLYILL PATIENTS, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1275-1280

Authors: HEINEMANN V KAHNY B JEHN U MUHLBAYER D DEBUS A WACHHOLZ K BOSSE D KOLB HJ WILMANNS W

Citation: V. Heinemann et al., SERUM PHARMACOLOGY OF AMPHOTERICIN-B APPLIED IN LIPID EMULSIONS, Antimicrobial agents and chemotherapy, 41(4), 1997, pp. 728-732

Authors: UNSELD H KAHNY B

Citation: H. Unseld et B. Kahny, PREVENTION OF POSTOPERATIVE VOMITING THRO UGH THE USE OF HISTAMINE-RECEPTOR ANTAGONISTS, Anasthesiologie und Intensivmedizin, 37(1), 1996, pp. 29-34

Authors: HEINEMANN V KAHNY B DEBUS A WACHHOLZ K JEHN U

Citation: V. Heinemann et al., PHARMACOKINETICS OF LIPOSOMAL AMPHOTERICIN-B (AMBISOME) VERSUS OTHER LIPID-BASED FORMULATIONS, Bone marrow transplantation, 14, 1994, pp. 8-9